CRISPR extends lifespan of Lou Gehrigs disease mice by 25% – Next Big Future
Next Big Future |
CRISPR extends lifespan of Lou Gehrigs disease mice by 25%
Next Big Future The therapy delayed the onset of the muscle wasting that characterizes the disease, which results in progressive weakness and eventually proves fatal when the muscles that control breathing fail. This step toward a CRISPR cure for human ALS will be … Gene Editing Delays Disease Onset in ALS Model Mice |
